Emerillon Capital
Emerillon Capital is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Emerillon Capital.
Emerillon Capital is a company.
Key people at Emerillon Capital.
Key people at Emerillon Capital.
Emerillon Capital is a Montreal-based venture capital firm specializing in equity and quasi-equity investments for early-stage technology companies, primarily in Quebec, Ontario, and the northeastern United States.[1][2] Its mission focuses on supporting firms with strong technological expertise during pre-revenue, commercial startup, and initial expansion phases, targeting high-growth sectors like information technology, communications, health/medical, clean technologies, and security/defense, with investment sizes ranging from $0.5M to $5M over 7-9 year terms.[1] Backed by Credit Mutuel CIC (via CM-CIC Capital Finance) and Desjardins, Emerillon accelerates commercialization and expansion, leveraging European networks for portfolio growth, and has invested in companies like CM Labs Simulations (simulation software) and Q4 (fintech).[2][3]
The firm emphasizes criteria such as quality management teams, strong IP barriers, competitive advantages, market potential, and long-term viability, positively impacting the startup ecosystem by bridging Canadian tech innovators to international opportunities, particularly in Europe.[1][2]
Emerillon Capital emerged from a partnership combining the strengths of Credit Mutuel CIC (through its Canadian subsidiary CM-CIC Capital Finance and VCIC Inc.) and Desjardins, creating a dedicated fund to bolster technology companies in Canada and the northeastern U.S.[1][2] Established around 2010 in Montreal—when CIC Capital Canada began managing the fund—Emerillon has evolved to focus on early-stage tech investments, with management delegated to VCIC Inc.[1][6] Key figures include Investment Director Ann Girard, who highlighted investments like CM Labs in 2013 press releases.[2] Its evolution reflects a shift toward leveraging sponsor networks for cross-Atlantic support, as seen in deals with Fonds de solidarité FTQ for pharma investments like Searchlight Pharma.[5]
Emerillon Capital rides the wave of Canada's burgeoning tech ecosystem, particularly in Quebec's innovation hubs like Montreal, fueling early-stage growth amid rising demand for AI, health tech, clean energy, and simulation tools amid global digital transformation.[1][2] Timing aligns with post-2010 venture surges in North America, where cross-border networks counter limited local capital by linking to Europe—critical as U.S./Canadian startups seek international scale against market forces like talent shortages and IP competition.[1][6] It influences the ecosystem by channeling Quebecois savings (via partners like Fonds de solidarité FTQ) into high-potential tech, de-risking commercialization and boosting sectors like simulation training for safety-critical industries.[2][5]
Emerillon Capital is poised to deepen its role in scaling Canadian tech globally, potentially expanding into AI-driven health and clean tech as these sectors explode with sustainability mandates and digital adoption. Trends like Europe-North America tech corridors and Quebec's R&D incentives will shape its trajectory, with higher exit rates likely from maturing portfolios. Its influence may evolve toward larger follow-on rounds, solidifying as a key bridge for Northeast U.S./Canadian innovators—empowering the next wave of tech leaders from Montreal's vibrant scene.[1][2][4]
